SPP1 expression levels were markedly higher in older (≥ 60 years old) than in younger (< 60 years old) patients in BLCA, CESC, HNSC, LIHC, PRAD, SARC, and THYM. Here, SPP1 is linked to bladder transitional cell carcinoma.